ALKS peer analysis
Alkermes (ALKS) against its competitors: price, today's move, 1-year return and market value side by side.
ALKS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | $20.47 | -0.58% | -9.98% | $3.55B |
| AXSM Axsome Therapeutics | $136.07 | -5.79% | 2.19% | $7.57B |
| JAZZ Jazz Pharmaceuticals | $214.64 | -0.62% | 57.48% | $14.02B |
| NBIX Neurocrine Biosciences | $156.00 | 6.78% | 13.01% | $14.85B |
| SUPN Supernus Pharmaceuticals | $41.92 | 0.19% | -25.81% | $2.44B |
| VNDA Vanda Pharmaceuticals | $3.79 | -6.42% | -12.27% | $229.18M |
| ALKS Alkermes | $44.94 | -0.88% | 45.81% | $7.61B |
- ALKS's peers: ACAD (Acadia Pharmaceuticals), AXSM (Axsome Therapeutics), JAZZ (Jazz Pharmaceuticals), NBIX (Neurocrine Biosciences), SUPN (Supernus Pharmaceuticals), VNDA (Vanda Pharmaceuticals).
Updated 2026-11-02 23:12 UTC